Neurosurgery asks AI to help answer hard questions about injured brains

One of the medical specialties highly hopeful in AI’s potential to guide care is neurosurgery. That’s because patients with traumatic brain injuries often present care teams and family members with an especially thorny decision:

Operate to potentially save a life or withhold surgery to possibly avoid severe postsurgical disabilities?

Stat News drills into the ways AI can help guide such decisions in a piece posted Aug. 14.

The article’s author, Duke neurosurgeon Jacquelyn Corley, MD, wraps her discussion around the case of an elderly patient who arrived in a trauma center after a car crash. The man was unconscious and showed signs of an accumulating brain bleed.   

“[S]urgery could save the patient’s life, but it could also commit him to a life dependent on a ventilator and a feeding tube, trapped in a coma or with limited brain function,” Corley writes. “Sometimes the quality of life matters more than just the presence of it. The challenge is how can doctors and family members make the right decision in these rushed and emotional moments.”

After breaking down the assistance AI can introduce into these scenarios—and outlining some of its persistent pitfalls, like biased data, privacy concerns and lack of regulations—Corley observes “an emerging consensus that AI could be useful for determining a prognosis for traumatic brain injury patients, and that it could aid clinicians, families and patients in making a shared decision about the best course of treatment.”

AI tools can “help guide the conversation,” she adds, quoting a fellow neurosurgeon, “but doctors need to make sure to use AI technology as a guiding tool only … and not as a replacement for old-fashioned clinical judgment.”

Read the whole thing:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup